Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Ceesay Abraham (CIK 1722140) reported 45 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-09-24). Recent activity: Sell RAPP (1,952 shares), Sell RAPP (215 shares), Sell RAPP (43 shares), Sell RAPP (7,141 shares), Sell RAPP (1,069 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-24 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 1,952 | $76,230 |
| 2026-09-24 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 215 | $8,570 |
| 2026-09-24 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 43 | $1,765 |
| 2026-09-09 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 7,141 | $325,308 |
| 2026-09-09 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 1,069 | $49,190 |
| 2026-08-26 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 18,921 | $937,957 |
| 2026-08-12 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 14,171 | $651,492 |
| 2026-08-12 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 8,370 | $391,280 |
| 2026-08-12 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 3,664 | $171,837 |
| 2026-08-12 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 19,500 | $936,846 |
| 2026-08-12 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 5,794 | $281,721 |
| 2026-07-29 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,203 | $92,762 |
| 2026-07-29 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 7 | $299 |
| 2026-07-15 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 5,481 | $217,715 |
| 2026-07-15 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,729 | $110,722 |
| 2026-07-01 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 7,344 | $292,062 |
| 2026-07-01 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 876 | $35,336 |
| 2026-05-11 | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | Director | Buy | 1,438 | $255,418 |
| 2026-02-19 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 3,552 | $103,186 |
| 2026-02-19 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,281 | $67,974 |
| 2026-02-19 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,983 | $86,626 |
| 2026-02-19 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,100 | $62,580 |
| 2026-01-22 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 5,833 | $152,358 |
| 2026-01-22 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 5,083 | $132,717 |
| 2025-12-18 | Rapport Therapeutics, Inc. (RAPP) | Chief Executive Officer | Sell | 2,441 | $70,398 |
Source: SEC Form 4 filings · as of 2026-09-24